-The Guardian  The counter conference is designed to foster alternative ideas and provide an outlet for discontent They come with speeches, placards, power point presentations and drums. Some with body paint and bows and arrows. Others with suits and business plans. Almost all driven by a desire for radical change. "Come re-invent the world" is the call to the People's summit, which has opened in Rio de Janeiro to counter what many participants...

-The Economic Times   Pushed to the wall by an overly cautious drug regulator and an alarmist Indian government, clinical trial companies are looking at South East Asian countries to expand their business and escape the red tape of Indian authorities.  Clinical research companies (CROs), that were aspiring to become billion- dollar companies by 2010, had to rework their plans after a Parliamentary Standing Committee report questioned the allegedly unfair and unethical trials...

RANWAN, India — In this north Indian village, workers recently dismantled stacks of burned and mildewed rice while flies swarmed nearby over spoiled wheat. Local residents said the rice crop had been sitting along the side of a highway for several years and was now being sent to a distillery to be turned into liquor. Just 180 miles to the south, in a slum on the outskirts of New Delhi, Leela...

Atomic Energy Regulatory Board's clearance being awaited Expressing satisfaction over the progress in preparing the first reactor of Kudankulam Nuclear Power Project for commissioning, Nuclear Power Corporation of India Limited (NPCIL) Chairman and Managing Director S.K. Jain has said the KKNPP was waiting for the Atomic Energy Regulatory Board's clearance for the opening of the reactor pressure vessel for inspecting the internal components' performance and subsequent loading of enriched uranium fuel...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...